These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 36682438)

  • 1. Artificial intelligence aids in development of nanomedicines for cancer management.
    Tan P; Chen X; Zhang H; Wei Q; Luo K
    Semin Cancer Biol; 2023 Feb; 89():61-75. PubMed ID: 36682438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating Artificial Intelligence and Nanotechnology for Precision Cancer Medicine.
    Adir O; Poley M; Chen G; Froim S; Krinsky N; Shklover J; Shainsky-Roitman J; Lammers T; Schroeder A
    Adv Mater; 2020 Apr; 32(13):e1901989. PubMed ID: 31286573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial intelligence to bring nanomedicine to life.
    Serov N; Vinogradov V
    Adv Drug Deliv Rev; 2022 May; 184():114194. PubMed ID: 35283223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-envisioning the design of nanomedicines: harnessing automation and artificial intelligence.
    Zaslavsky J; Bannigan P; Allen C
    Expert Opin Drug Deliv; 2023 Feb; 20(2):241-257. PubMed ID: 36644850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organoids technology for advancing the clinical translation of cancer nanomedicine.
    Zhao DK; Liang J; Huang XY; Shen S; Wang J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1892. PubMed ID: 37088100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Pharmaceutical Nanomedicines: From the Bench to the Market.
    Halwani AA
    Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A concise review: the synergy between artificial intelligence and biomedical nanomaterials that empowers nanomedicine.
    Hayat H; Nukala A; Nyamira A; Fan J; Wang P
    Biomed Mater; 2021 Aug; 16(5):. PubMed ID: 34280907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-Generation Polymeric Nanomedicines for Oncology: Perspectives and Future Directions.
    Fletcher NL; Kempe K; Thurecht KJ
    Macromol Rapid Commun; 2020 Sep; 41(18):e2000319. PubMed ID: 32767396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer nanomedicine toward clinical translation: Obstacles, opportunities, and future prospects.
    Zhang P; Xiao Y; Sun X; Lin X; Koo S; Yaremenko AV; Qin D; Kong N; Farokhzad OC; Tao W
    Med; 2023 Mar; 4(3):147-167. PubMed ID: 36549297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of artificial intelligence in cancer diagnosis and tumor nanomedicine.
    Wang J; Liu G; Zhou C; Cui X; Wang W; Wang J; Huang Y; Jiang J; Wang Z; Tang Z; Zhang A; Cui D
    Nanoscale; 2024 Aug; 16(30):14213-14246. PubMed ID: 39021117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of Drug Delivery Technology and Nanomedicine by Using Gold Nanoparticles].
    Ozeki T; Tagami T
    Yakugaku Zasshi; 2021; 141(3):323-326. PubMed ID: 33642498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in Nanomedicines for Cancer Treatment.
    do Nascimento T; Todeschini AR; Santos-Oliveira R; de Souza de Bustamante Monteiro MS; de Souza VT; Ricci-JĂșnior E
    Curr Pharm Des; 2020; 26(29):3579-3600. PubMed ID: 32186271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicines for back of the eye drug delivery, gene delivery, and imaging.
    Kompella UB; Amrite AC; Pacha Ravi R; Durazo SA
    Prog Retin Eye Res; 2013 Sep; 36():172-98. PubMed ID: 23603534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theranostic nanomedicine.
    Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
    Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation targeted nanomedicines: Patents and applications in cancer therapy.
    Praveen TK; Gangadharappa HV; Abu Lila AS; Moin A; Mehmood K; Krishna KL; Hussain T; Alafnan A; Shakil S; Rizvi SMD
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):645-663. PubMed ID: 35405339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnology as a Delivery Tool for Precision Cancer Therapies.
    Sharma B; Crist RM; Adiseshaiah PP
    AAPS J; 2017 Nov; 19(6):1632-1642. PubMed ID: 29019032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalized Nanoparticles for Cancer Therapy: A Call for Greater Precision.
    Sahakyan N; Haddad A; Richardson S; Forcha-Etieundem V; Christopher L; Alharbi H; Campbell R
    Anticancer Agents Med Chem; 2017; 17(8):1033-1039. PubMed ID: 28042778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating Nanomedicines: Obstacles and Advancements.
    Swierczewska M; Crist RM; McNeil SE
    Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knowledge Gaps in Generating Cell-Based Drug Delivery Systems and a Possible Meeting with Artificial Intelligence.
    Mozafari N; Mozafari N; Dehshahri A; Azadi A
    Mol Pharm; 2023 Aug; 20(8):3757-3778. PubMed ID: 37428824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimally invasive nanomedicine: nanotechnology in photo-/ultrasound-/radiation-/magnetism-mediated therapy and imaging.
    Ouyang J; Xie A; Zhou J; Liu R; Wang L; Liu H; Kong N; Tao W
    Chem Soc Rev; 2022 Jun; 51(12):4996-5041. PubMed ID: 35616098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.